Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

Matched clinical trials

  • Study on Lutetium (177Lu) Zadavotide Guraxetan for Patients with Recurrent Grade 3 and Grade 4 Glioma

    Not yet recruiting

    2 1 1 1
    Investigated diseases:
    Norway
  • Study on the Safety and Effectiveness of Vorasidenib and Temozolomide for Patients with IDH1 or IDH2 Mutant Glioma

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Austria France Germany Italy The Netherlands Spain
  • Study on the Safety and Effectiveness of Sirolimus for Treating High-Grade Glioma in Children

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Poland
  • Study of Abemaciclib and Temozolomide for Children and Young Adults with Newly Diagnosed High-Grade Glioma After Radiotherapy

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium Denmark France Italy The Netherlands Romania +1
  • Study of WT1 LAMP mRNA DC Immunotherapy for Children with High-Grade Glioma and Diffuse Intrinsic Pontine Glioma

    Not recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium
  • Study Comparing Fluciclovine (18F) and Fluoroethyltyrosine F-18 PET Scans in Patients with New or Recurrent Brain Tumors and Brain Metastases

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Germany
  • Study of Lenvatinib for Children and Young Adults with Relapsed or Refractory Solid Tumors, Including High Grade Glioma and Rhabdomyosarcoma

    Not recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    Czechia France Italy Spain
  • Study of Vorasidenib for Patients with Residual or Recurrent Grade 2 Glioma with IDH1 or IDH2 Mutation

    Not recruiting

    3 1
    Investigated diseases:
    Investigated drugs:
    France Germany Italy The Netherlands Spain
  • Study of Nivolumab with Chemotherapy for Children and Teenagers with Refractory or Relapsing Solid Tumors or Lymphoma

    Not recruiting

    1 1 1 1
    Investigated diseases:
    France
  • Study of Cobolimab and Dostarlimab for Children and Young Adults with Newly Diagnosed or Relapsed/Refractory Tumors

    Not recruiting

    1 1 1 1
    Investigated drugs:
    Czechia Denmark France Germany Italy Spain